Echo Therapeutics Inc (ECTE) Financial Statements (2024 and earlier)
Company Profile
Business Address |
99 WOOD AVENUE SOUTH ISELIN, NJ 08830 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 939 | 43 | 56 | 3 | 337 | 469 | |||
Cash and cash equivalents | 939 | 43 | 56 | 3 | 337 | 469 | |||
Other undisclosed current assets | 263 | 332 | 245 | 223 | 343 | 447 | |||
Total current assets: | 1,202 | 375 | 301 | 227 | 680 | 917 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 210 | 237 | 302 | 443 | 931 | ||||
Intangible assets, net (including goodwill) | 9,625 | ||||||||
Intangible assets, net (excluding goodwill) | 9,625 | ||||||||
Other noncurrent assets | 0 | 0 | 0 | 0 | 0 | 130 | |||
Assets held-for-sale, long lived | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 2,554 | ||
Other undisclosed noncurrent assets | 251 | 137 | 236 | (66) | (264) | (3,485) | |||
Total noncurrent assets: | 460 | 374 | 237 | 237 | 180 | 9,755 | |||
Other undisclosed assets | 210 | 237 | 268 | 302 | 443 | 931 | |||
TOTAL ASSETS: | 1,871 | 986 | 805 | 765 | 1,304 | 11,602 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 1,999 | 2,462 | 2,778 | 2,233 | 2,165 | 1,734 | |||
Accounts payable | 1,615 | 1,998 | 2,176 | 1,916 | 1,514 | 1,369 | |||
Accrued liabilities | 384 | 464 | 602 | 318 | 651 | 365 | |||
Debt | 2,351 | 868 | |||||||
Derivative instruments and hedges, liabilities | 4,687 | 1,603 | 127 | 270 | 635 | 3,309 | |||
Other undisclosed current liabilities | 112 | 729 | 330 | 29 | 46 | 213 | |||
Total current liabilities: | 9,149 | 5,662 | 3,235 | 2,532 | 2,846 | 5,256 | |||
Noncurrent Liabilities | |||||||||
Liabilities, other than long-term debt | 96 | 96 | 96 | 96 | 96 | 96 | |||
Deferred revenue and credits | 96 | 96 | 96 | 96 | 96 | 96 | |||
Total noncurrent liabilities: | 96 | 96 | 96 | 96 | 96 | 96 | |||
Total liabilities: | 9,245 | 5,758 | 3,331 | 2,628 | 2,941 | 5,351 | |||
Equity | |||||||||
Equity, attributable to parent, including: | (7,374) | (4,772) | (2,526) | (1,862) | (1,690) | 6,251 | |||
Preferred stock, shares subscribed but unissued, subscriptions receivable | (300) | ||||||||
Common stock | 115 | 114 | 111 | 111 | 111 | 111 | |||
Additional paid in capital | 148,123 | 147,785 | 147,413 | 147,101 | 145,256 | 142,312 | |||
Accumulated deficit | (155,692) | (152,751) | (150,130) | (148,854) | (147,078) | (136,236) | |||
Other undisclosed equity, attributable to parent | 80 | 80 | 80 | 80 | 21 | 63 | |||
Other undisclosed equity | 52 | ||||||||
Total equity: | (7,374) | (4,772) | (2,526) | (1,862) | (1,638) | 6,251 | |||
TOTAL LIABILITIES AND EQUITY: | 1,871 | 986 | 805 | 765 | 1,304 | 11,602 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 1,087 | 81 | 250 | |||||
Financial services revenue | 1,087 | (325) | (54) | 250 | ||||
Cost of revenue (Financial Services Costs) | (5,534) | |||||||
Other undisclosed gross profit | 4,620 | |||||||
Gross profit: | 1,087 | 4,701 | 250 | (5,534) | ||||
Operating expenses | (1,482) | (1,656) | (1,297) | (1,458) | (12,276) | (2,509) | ||
Other undisclosed operating income (loss) | (1,087) | 325 | (4,701) | 54 | (250) | 5,534 | ||
Operating loss: | (1,482) | (1,656) | (1,297) | (1,458) | (12,276) | (2,509) | ||
Nonoperating income (expense) | (1,459) | (965) | 24 | (317) | 1,433 | (5,795) | ||
Debt instrument, convertible, beneficial conversion feature | (155) | |||||||
Other nonoperating income (expense) | (263) | 8 | ||||||
Interest and debt expense | (107) | (39) | (10) | (0) | (2) | (3) | ||
Income (loss) from continuing operations before income taxes: | (3,048) | (2,660) | (1,283) | (1,776) | (10,845) | (8,306) | ||
Other undisclosed loss from continuing operations | (3) | |||||||
Income (loss) from continuing operations: | (3,048) | (2,660) | (1,287) | (1,776) | (10,845) | (8,306) | ||
Income (loss) before gain (loss) on sale of properties: | (3,048) | (2,660) | (1,287) | (1,776) | (10,845) | (8,306) | ||
Net income (loss): | (3,048) | (2,660) | (1,287) | (1,776) | (10,845) | (8,306) | ||
Other undisclosed net income attributable to parent | 107 | 39 | 10 | 0 | 2 | 3 | ||
Net income (loss) attributable to parent: | (2,941) | (2,621) | (1,276) | (1,775) | (10,843) | (8,304) | ||
Preferred stock dividends and other adjustments | (6,461) | |||||||
Net income (loss) available to common stockholders, diluted: | (9,402) | (2,621) | (1,276) | (1,775) | (10,843) | (8,304) |
Comprehensive Income ($ in thousands)Annual | Quarterly
9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (3,048) | (2,660) | (1,287) | (1,776) | (10,845) | (8,306) | ||
Comprehensive income (loss), net of tax, attributable to parent: | (3,048) | (2,660) | (1,287) | (1,776) | (10,845) | (8,306) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.